Adverum Biotechnologies, Inc.

Historical 13F Holders

Symbol
ADVM
CUSIP
00773U207
All holders as of
Q3 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00773U207 since 12/18/2024, largest first.

Filer % of Class Filed
Rush Ryan Bradford 13G 5.1% 12/17/2024
Event 12/17/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
BlackRock, Inc. 13G/A 2.0% 7/16/2025
Event 6/30/2025
Franklin Resources, Inc. 13G/A
0% 8/5/2025
Event 6/30/2025
Frazier Life Sciences Public Fund, L.P. 13G/A
0% 12/9/2025
Event 12/9/2025
Venrock Healthcare Capital Partners III, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 52 13.6 M $61.5 M
2025 Q2 60 13.5 M $29.1 M
2025 Q1 73 15.8 M $67.6 M
2024 Q4 72 15.4 M $71.8 M
2024 Q3 80 16.4 M $117 M
2024 Q2 75 15.9 M $104 M
2024 Q1 63 14.3 M $202 M